Ying-rong Leng

Limb expression 1-like (LIX1L) protein promotes cholestatic liver injury by regulating bile acid metabolism.

Lingyi Kong, Xiao-yun Zhu, Yanqiu Zhang, 2021, Journal of hepatology.

Physalin B ameliorates nonalcoholic steatohepatitis by stimulating autophagy and NRF2 activation mediated improvement in oxidative stress.

Lingyi Kong, Xiao-yun Zhu, Jieping Li, 2020, Free radical biology & medicine.

TKF, a mexicanolide-type limonoid derivative, suppressed hepatic stellate cells activation and liver fibrosis through inhibition of the YAP/Notch3 pathway.

L. Kong, Jun Luo, Xiao-yun Zhu, 2022, Phytomedicine : international journal of phytotherapy and phytopharmacology.

Pathogenesis of NASH and Promising Natural Products.

Jianguang Luo, Hao Zhang, Mei-hui Zhang, 2021, Chinese journal of natural medicines.

Physalin B attenuates liver fibrosis via suppressing LAP2α–HDAC1‐mediated deacetylation of the transcription factor GLI1 and hepatic stellate cell activation

L. Kong, Jianguang Luo, Xiao-yun Zhu, 2021, British journal of pharmacology.

MicroRNA and long noncoding RNA involvement in gout and prospects for treatment.

Lingyi Kong, Yi-ting Xu, Yingrong Leng, 2020, International immunopharmacology.

RNA helicase DEAD‐box protein 5 alleviates nonalcoholic steatohepatitis progression via tethering TSC complex and suppressing mTORC1 signaling

L. Kong, Jun Luo, Yanqiu Zhang, 2022, Hepatology.

Lefamulin Overcomes Acquired Drug Resistance via Regulating Mitochondrial Homeostasis by Targeting ILF3 in Hepatocellular Carcinoma

Yanqiu Zhang, Hao Zhang, Shengtao Ye, 2024, Advanced science.